Amneal Pharmaceuticals, Inc. (AMRX) Q1 FY26 Earnings Call

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Call date2026-04-23
Length61 minutes
EPS$0.25
EPS consensus$0.25
Revenue$722.5M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All AMRX earnings ยท Back to AMRX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.